Clinical Trial Update: Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses ABBV-706 alone or in combination with budigalimab, cisplatin, or carboplatin in adults with advanced solid tumors, focusing on adver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ABBV-706
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• budigalimab (budigalimab)

Snippet

Sponsor: AbbVie | Conditions: Advanced Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING